WEBSITE BSE:590031 NSE: DE NORA Inc. Year: 1993 Industry: Electrodes & Welding Equipment My Bucket: Add Stock
Last updated: 15:19
No Notes Added Yet
1. Business Overview
De Nora India Ltd. is an Indian subsidiary of De Nora S.p.A. (Italy), a global leader in electrochemistry. The company primarily manufactures and supplies electrodes and related electrochemical products. Its core business revolves around providing critical components for various industrial processes, including chlor-alkali production, electro-galvanizing, cathodic protection, water treatment, and other industrial electrochemistry applications. They also offer associated services like technical support and refurbishment of electrodes. The company makes money by selling these specialized electrodes, coatings, and systems directly to industrial clients and through long-term service contracts.
2. Key Segments / Revenue Mix
De Nora India's primary revenue streams are derived from:
Electrodes & Anodes: This includes dimensionally stable anodes (DSAs), platinum-group metal (PGM) coated electrodes, and other specialized electrode technologies used in various electrochemical processes. This forms the bulk of their revenue.
Cathodic Protection Systems: Solutions for preventing corrosion in pipelines, storage tanks, and other metal structures.
Water Technologies: Electrochlorination systems and other electrochemical solutions for water and wastewater treatment.
Services: Refurbishment, maintenance, and technical consulting related to their products.
Specific percentage breakdowns are not consistently disclosed, but electrodes and anodes for industrial applications represent the dominant segment.
3. Industry & Positioning
De Nora India operates in the specialized segment of the broader Electrodes & Welding Equipment sector, focusing heavily on electrochemical applications rather than general welding. The industry is characterized by the need for advanced materials science and engineering expertise. De Nora India, being a part of the global De Nora group, benefits from its parent's extensive R&D capabilities, technological leadership, and global brand recognition in electrochemical solutions. This positions them as a leading player in sophisticated industrial electrode systems within India, particularly in segments like chlor-alkali where specialized anodes are critical. Competition comes from other global players with local presence and a few domestic manufacturers, though De Nora often targets high-value, high-performance applications.
4. Competitive Advantage (Moat)
Technology & R&D: The most significant moat is derived from its parent company, De Nora S.p.A.'s, proprietary technology and continuous R&D. This allows De Nora India to offer advanced, high-performance, and energy-efficient electrode solutions (e.g., DSAs) that are difficult for competitors to replicate.
Brand & Reputation: A strong global brand reputation for quality, reliability, and technical expertise in electrochemical solutions.
Switching Costs: For large industrial clients, switching electrode suppliers can be complex and costly due due to process integration, performance guarantees, and the critical nature of these components to their operations.
Scale & Niche Specialization: Focus on niche, high-value industrial applications rather than commoditized products, leveraging specialized manufacturing processes.
5. Growth Drivers
Industrial Growth in India: Increased demand from end-user industries such as chlor-alkali, metals (e.g., zinc, copper), chemicals, and infrastructure development projects.
Focus on Energy Efficiency: Industries are increasingly seeking more energy-efficient processes, and De Nora's advanced electrodes often offer significant energy savings.
Water & Wastewater Treatment: Growing focus on water infrastructure and environmental compliance drives demand for electrochemical water treatment solutions.
Parent Company's Innovation: Leverage global R&D from De Nora S.p.A. to introduce new products and applications to the Indian market.
Expansion of Existing Facilities: Capacity expansion in core industries can lead to increased demand for their products.
6. Risks
Cyclicality of End-User Industries: Demand for De Nora's products is tied to the capital expenditure cycles and operational activity of heavy industries, making it susceptible to economic downturns.
Raw Material Price Volatility: Fluctuations in prices of key raw materials, especially precious metals (e.g., platinum, ruthenium, iridium) used in electrode coatings, can impact profitability.
Technological Obsolescence: While less likely given parent R&D, rapid advancements in electrochemical processes or alternative technologies could pose a risk.
Intense Competition: While having a niche, the industry still faces competition from other global and local players.
Regulatory Changes: Environmental regulations can impact end-user industries, affecting demand.
7. Management & Ownership
De Nora India Ltd. is majority-owned and promoted by De Nora S.p.A. (Italy), which holds a significant stake (often around 70%). This ensures strong corporate governance standards, access to global technological expertise, and strategic alignment with the parent company's global vision. The management team typically comprises experienced professionals with deep industry knowledge, benefiting from the global group's leadership and technical guidance.
8. Outlook
De Nora India benefits significantly from its technological prowess and established reputation as part of a global leader in electrochemistry. The company is well-positioned to capitalize on India's industrial growth, increasing demand for energy-efficient solutions, and focus on water treatment infrastructure. However, its performance remains sensitive to the cyclical nature of heavy industries and raw material price volatility. The strong parentage provides a stable foundation for long-term growth and innovation, but short-to-medium term prospects will be influenced by the health of the broader industrial economy.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹379 Cr.
Stock P/E 224.2
P/B 2.9
Current Price ₹714.9
Book Value ₹ 243.6
Face Value 10
52W High ₹995
Dividend Yield 0%
52W Low ₹ 559
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 29 | 16 | 13 | 18 | 18 | 20 | 42 | 22 | 36 | 22 |
| Other Income | 1 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 2 |
| Total Income | 31 | 18 | 14 | 20 | 19 | 22 | 44 | 24 | 37 | 24 |
| Total Expenditure | 22 | 10 | 10 | 15 | 29 | 16 | 40 | 18 | 33 | 24 |
| Operating Profit | 9 | 8 | 4 | 5 | -10 | 5 | 5 | 6 | 4 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 8 | 8 | 4 | 4 | -10 | 5 | 4 | 5 | 3 | -1 |
| Provision for Tax | 2 | 2 | 1 | 1 | -3 | 1 | 1 | 1 | 1 | -0 |
| Profit After Tax | 6 | 6 | 3 | 3 | -8 | 3 | 3 | 4 | 3 | -1 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 6 | 6 | 3 | 3 | -8 | 3 | 3 | 4 | 3 | -1 |
| Adjusted Earnings Per Share | 12.2 | 10.7 | 5.4 | 6.2 | -14.7 | 6.3 | 6.1 | 7.3 | 4.8 | -1.2 |
| #(Fig in Cr.) | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 31 | 51 | 27 | 27 | 33 | 48 | 51 | 74 | 74 | 74 | 69 | 122 |
| Other Income | 2 | 4 | 3 | 3 | 4 | 2 | 2 | 1 | 4 | 5 | 6 | 7 |
| Total Income | 33 | 55 | 30 | 30 | 37 | 51 | 52 | 75 | 77 | 79 | 74 | 129 |
| Total Expenditure | 25 | 35 | 25 | 25 | 32 | 38 | 42 | 51 | 49 | 52 | 70 | 115 |
| Operating Profit | 7 | 19 | 5 | 5 | 4 | 13 | 10 | 24 | 29 | 27 | 5 | 15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 1 | 1 | 2 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 6 | 18 | 4 | 3 | 2 | 10 | 8 | 21 | 27 | 25 | 3 | 11 |
| Provision for Tax | 2 | 6 | 1 | 1 | 0 | 2 | 2 | 6 | 7 | 6 | 1 | 3 |
| Profit After Tax | 4 | 12 | 3 | 2 | 2 | 8 | 6 | 15 | 20 | 19 | 2 | 9 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 4 | 12 | 3 | 2 | 2 | 8 | 6 | 15 | 20 | 19 | 2 | 9 |
| Adjusted Earnings Per Share | 8 | 22.6 | 5.6 | 3.2 | 3 | 15.3 | 10.6 | 29.1 | 38.2 | 35.8 | 3.2 | 17 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -7% | -2% | 8% | 8% |
| Operating Profit CAGR | -81% | -41% | -17% | -3% |
| PAT CAGR | -89% | -49% | -24% | -7% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -16% | -22% | 19% | 8% |
| ROE Average | 1% | 14% | 14% | 12% |
| ROCE Average | 2% | 18% | 19% | 17% |
| #(Fig in Cr.) | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 39 | 49 | 52 | 52 | 53 | 61 | 67 | 82 | 102 | 120 | 120 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -1 | -1 | -1 | -0 | 6 | -1 | -1 | 3 | 10 | -1 | -3 |
| Total Current Liabilities | 8 | 12 | 11 | 10 | 11 | 14 | 13 | 17 | 14 | 7 | 22 |
| Total Liabilities | 47 | 59 | 62 | 62 | 71 | 74 | 79 | 102 | 125 | 126 | 139 |
| Fixed Assets | 7 | 7 | 7 | 14 | 12 | 10 | 10 | 7 | 8 | 13 | 15 |
| Other Non-Current Assets | 3 | 13 | 10 | 4 | 10 | 2 | 1 | 6 | 14 | 12 | 16 |
| Total Current Assets | 37 | 38 | 45 | 45 | 49 | 62 | 68 | 88 | 103 | 101 | 109 |
| Total Assets | 47 | 59 | 62 | 62 | 71 | 74 | 79 | 102 | 125 | 126 | 139 |
| #(Fig in Cr.) | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 1 | 3 | 1 | 2 | 2 | 19 | 14 | 4 | 5 |
| Cash Flow from Operating Activities | 10 | 14 | 7 | 2 | -6 | -7 | 16 | 12 | 14 | 16 | 3 |
| Cash Flow from Investing Activities | -8 | -12 | -3 | -2 | 7 | 7 | 1 | -16 | -24 | -14 | 1 |
| Cash Flow from Financing Activities | -3 | -1 | -3 | -1 | -1 | 1 | -1 | -1 | -1 | -1 | -1 |
| Net Cash Inflow / Outflow | -1 | 1 | 1 | -2 | 1 | 1 | 16 | -5 | -10 | 1 | 3 |
| Closing Cash & Cash Equivalent | 0 | 1 | 3 | 1 | 2 | 2 | 19 | 14 | 4 | 5 | 8 |
| # | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 8.01 | 22.56 | 5.61 | 3.18 | 2.99 | 15.31 | 10.64 | 29.1 | 38.19 | 35.8 | 3.19 |
| CEPS(Rs) | 10.27 | 24.74 | 7.22 | 7.19 | 7.76 | 20.19 | 15.54 | 34.13 | 40.77 | 37.96 | 6.39 |
| DPS(Rs) | 1.5 | 4 | 2 | 1 | 0 | 0 | 1 | 1 | 2 | 2 | 0 |
| Book NAV/Share(Rs) | 73.96 | 91.66 | 97.81 | 98.66 | 100.26 | 115.53 | 126.16 | 154.24 | 191.53 | 225.46 | 226.33 |
| Core EBITDA Margin(%) | 16.43 | 29.91 | 7.39 | 7.15 | 1.46 | 21.87 | 16.65 | 30.87 | 33.64 | 28.93 | -1.84 |
| EBIT Margin(%) | 19.76 | 34.94 | 16.36 | 11.31 | 5.9 | 21.6 | 15.11 | 28.56 | 37.01 | 34.42 | 4.23 |
| Pre Tax Margin(%) | 19.24 | 34.71 | 16.12 | 11.28 | 5.55 | 21.47 | 14.99 | 28.26 | 36.9 | 34.18 | 4.02 |
| PAT Margin (%) | 13.59 | 23.11 | 10.81 | 6.2 | 4.84 | 16.85 | 11.17 | 20.83 | 27.56 | 25.76 | 2.47 |
| Cash Profit Margin (%) | 17.42 | 25.35 | 13.9 | 14 | 12.56 | 22.23 | 16.32 | 24.43 | 29.42 | 27.31 | 4.95 |
| ROA(%) | 9.08 | 22.65 | 4.92 | 2.71 | 2.38 | 11.18 | 7.37 | 17.1 | 17.84 | 15.13 | 1.28 |
| ROE(%) | 11.31 | 27.24 | 5.93 | 3.24 | 3.01 | 14.19 | 8.8 | 20.76 | 22.09 | 17.17 | 1.41 |
| ROCE(%) | 16.45 | 41.19 | 8.96 | 5.91 | 3.67 | 18.07 | 11.84 | 28.46 | 29.68 | 22.95 | 2.42 |
| Receivable days | 142.92 | 77.72 | 108.7 | 71.83 | 57.07 | 69.43 | 85.78 | 55.82 | 71.46 | 67.39 | 62.9 |
| Inventory Days | 105.43 | 44.45 | 73.02 | 79.93 | 132.4 | 162.4 | 163.88 | 106.44 | 130.13 | 138.96 | 156.71 |
| Payable days | 78.76 | 61.39 | 127.26 | 217.33 | 159.92 | 95.66 | 55.55 | 38.65 | 66.54 | 73.26 | 63.91 |
| PER(x) | 18.09 | 14.13 | 40.93 | 134.1 | 99.48 | 8.53 | 23.61 | 13.73 | 22.2 | 45.59 | 213.41 |
| Price/Book(x) | 1.96 | 3.48 | 2.35 | 4.33 | 2.97 | 1.13 | 1.99 | 2.59 | 4.43 | 7.24 | 3.01 |
| Dividend Yield(%) | 1.04 | 1.26 | 0.87 | 0.23 | 0 | 0 | 0.4 | 0.25 | 0.24 | 0.12 | 0 |
| EV/Net Sales(x) | 2.45 | 3.3 | 4.1 | 7.98 | 4.46 | 1.15 | 2.04 | 2.57 | 5.91 | 11.63 | 5.11 |
| EV/Core EBITDA(x) | 10.13 | 8.71 | 20.38 | 41.41 | 32.73 | 4.28 | 10.09 | 8 | 15.2 | 32.34 | 76.05 |
| Net Sales Growth(%) | -14.77 | 66.57 | -47.53 | 1.33 | 21.29 | 47.11 | 4.79 | 46.75 | -0.79 | 0.29 | -7.07 |
| EBIT Growth(%) | -14.73 | 192.73 | -75.11 | -31.65 | -37.19 | 438.26 | -26.67 | 177.31 | 28.57 | -6.73 | -88.57 |
| PAT Growth(%) | -10.95 | 181.62 | -75.11 | -43.28 | -6.11 | 412.16 | -30.54 | 173.67 | 31.23 | -6.26 | -91.09 |
| EPS Growth(%) | -10.95 | 181.62 | -75.11 | -43.28 | -6.11 | 412.16 | -30.54 | 173.67 | 31.23 | -6.26 | -91.09 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 4.44 | 3.33 | 3.98 | 4.4 | 4.3 | 4.48 | 5.38 | 5.2 | 7.61 | 14.48 | 4.97 |
| Quick Ratio(x) | 3.63 | 2.82 | 3.53 | 3.73 | 2.8 | 2.6 | 3.84 | 3.79 | 5.5 | 10.53 | 3.54 |
| Interest Cover(x) | 38 | 148.22 | 70.77 | 381.48 | 16.81 | 161.11 | 117.89 | 93.65 | 329.73 | 141.84 | 19.73 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.68 | 53.68 | 53.68 | 53.68 | 53.68 | 53.68 | 53.68 | 53.68 | 53.68 | 53.68 |
| FII | 0.19 | 0.11 | 0.1 | 0.09 | 0.1 | 0.14 | 0.03 | 0.01 | 0.01 | 0.72 |
| DII | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
| Public | 45.92 | 46 | 46.01 | 46.01 | 46 | 45.97 | 46.07 | 46.1 | 46.09 | 45.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.